| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Shire Human Genetic Therapies, Inc. is a 10% Owner at TAKEDA PHARMACEUTICAL CO LTD. Recent SEC Form 4 filings include 0 buys and 6 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2020 | TAK Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 6,824,992 | $20.68 | $141,140,834.56 | -100% | |
| Jun 3, 2020 | TAK Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 40,086 | $19.75 | $791,698.50 | -0.6% | |
| Jun 2, 2020 | TAK Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 213,867 | $19.81 | $4,237,024.07 | -0.8% |